Story here on bloomberg.
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
About Me
Blog Archive
-
▼
2007
(82)
-
▼
May
(10)
- Pfizer and GSK shares can only go up from here?
- End of the evergreening trend? WSJ blog handicaps ...
- Chantix Pricing in China
- Chantix Pricing in China: Pharmalyst Reports....
- End of the "evergreening" trend?
- Chantix/Champix - Developed country sales
- Purdue Pharma - A pusher of another kind
- NYT: Psychiatrists, Children and Drug Industry’s Role
- The making of a quiet blockbuster - Update
- The case for debt
-
▼
May
(10)
Links
- Brandweek NRx
- Clinical Psyc
- Dr. Peter Rost
- Drug Watcher
- E-Drug Search Blog
- Healthy Skepticism
- In the pipeline
- IN VIVO Blog
- Online Prescriptions
- Pfizer Sales Representative Bill of Rights
- Pharma Marketing Blog
- Pharma's cutting edge
- PharmaFraud
- PharmaGiles
- PharmaGossip
- Pharmalot
- PharmedOut
- Prescription Access Litigation
- Scientific Misconduct
- The numbers guy
- WSJ Health Blog
No comments:
Post a Comment